Rat intestinal transplantation is an optimal model for research; nevertheless, it requires a complex and difficult microsurgical technique (1) (2) (3) (4) (5) . We have recently developed a simplified rat model for intestinal transplantation using portal cuff anastomosis to overcome these technical difficulties (Fig. 1A) .
Preoperative procedures, anesthesia and laparotomy are performed as previously described (1) (2) (3) (4) . In the donor operation, middle and descending colons are isolated from small bowel and ascending colon. Superior mesenteric vein is dissected and encircled. Splenic and pyloric veins are divided and portal vein is dissected up to hepatic hilum. Abdominal aorta is dissected and celiac trunk, right renal artery and lumbar branches are divided. Aorta is clamped at the diaphragm, tied below the mesenteric artery and this arterial segment is resected allowing a long aortomesenteric conduit. Entire small bowel, cecum and ascending colon are harvested on a vascular pedicle consisting of right colonic vessels, aortomesenteric conduit and portal vein. The graft is flushed and stored in cold preservation solution.
Polyethylene catheter is used to create the cuff as described elsewhere (5). In this modified technique, the vein is introduced into the cuff and everted, covering the outer wall and fixed with three equidistant stitches (Fig. 1B) .
In the recipient, the superior mesenteric vein is exposed, and a segment between the first and second jejunal branch is dissected and prepared for cuff anastomosis. Eventually, the second jejunal branches and the right colonic vein may be divided in order to increase this segment. The graft is implanted in the recipient with an end-to-side aortoaorta anastomosis as previously described (1-5). The dissected segment of mesenteric vein is isolated between clamps to insert the portal cuff and a 6-0 suture is used to fix the cuff into recipient's mesenteric vein. The clamps are released and immediate graft reperfusion is observed. The recipient jejunum, ileum, cecum, and ascending colon are removed en bloc. Finally, anastomosis between the graft and the remaining intestine restores the digestive tract (Fig.  1A ).
The 
␥␦ T Cells and Resolution of Cytomegalovirus Infection in an HIV/HCV Coinfected Patient after Liver Transplantation
Cytomegalovirus (CMV) infection is a frequent transplant complication. Anti-CMV responses in allograft recipients have been extensively studied, only few reports addressing ␥␦ T lymphocytes role (1, 2) . ␥␦ T cells may play a natural antiviral role (3), and kidney allograft recipients during CMV infection undergo a massive expansion of circulating ␥␦ T cells (4). The occurrence of a primary CMV infection in a highly immunosuppressed patient may represent a model about the role of innate immunity in this setting.
We analyzed a 41-year-old human immunodeficiency virus (HIV)/hepatitis C virus (HCV) coinfected patient undergoing primary CMV infection after orthotopic liver transplantation (OLT). The donor was negative for antibodies to HIV-1/2 or HCV, but positive for CMV IgG. At day 42 after OLT, the patient suffered from fever (Ͼ38°C for more than 2 days), leukopenia (Ͻ4ϫ10 9 leukocytes/L in Ͼ2 consecutive samples) and malaise. CMV infection resolved within day 60. No CMV prophylaxis or treatment were performed and CMV infection was retrospectively diagnosed. Thus, resolution was only dependent on the host-response. At day 45, CMV-DNA was transiently positive; anti-CMV IgM and IgG were observed at days 99 and 112, respectively.
As V␦1 T lymphocytes are specifically expanded by both chronic HIV (5, 6) or acute CMV infections (1, 2) , the distribution of this ␥␦ T cell subset was compared to the kinetics of CMV-and HIV-specific CD8 T cell responses (Fig.  1) . Lymphocytes showed a transient decrease at CMV viremia and disease onset (day 45, Fig. 1A ). V␦1 T cells increased at day 2, decreased at the time of clinical disease at day 45 and dropped at day 72, suggesting a ␥␦-specific T cell exhaustion and/or tissue migration. A subsequent increase of V␦1 T cells was ob- 
